FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 339:1547-1549 November 19, 1998 Number 21 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Hasenclever, D. PubMed Citation

Advanced Hodgkin's disease is usually defined according to the Ann Arbor clinical staging system. Patients often have stage III disease (involvement of lymph nodes on both sides of the diaphragm) or stage IV disease (involvement of one or more extranodal sites) at the time of presentation, and such patients constitute about 30 percent of those with newly diagnosed Hodgkin's disease. But the Ann Arbor staging system does not always identify patients with advanced Hodgkin's disease adequately. After treatment with a combination of chemotherapy and radiotherapy, patients with stage IIIA disease (no systemic symptoms, which include fever, night sweats, and weight . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.